US Stock MarketDetailed Quotes

ORGO Organogenesis

Watchlist
  • 3.050
  • -0.060-1.93%
Close Dec 20 16:00 ET
  • 3.050
  • 0.0000.00%
Post 20:01 ET
383.46MMarket Cap-61.00P/E (TTM)

Organogenesis Key Stats

Organogenesis Q3 2024 Earnings Date

Currency:USDNov 12, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
109.47M
115.18M
+5.71M
Beat Est.
+0.86%
+6.12%
+5.22%
EPS
-0.01
0.09
+0.10
Beat Est.
-174.50%
+350.00%
+704.03%
Strong Buy

Dec 22, 2024

Organogenesis Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 114.700M--
--2024/Q4-- / 109.600M--
Nov 12, 20242024/Q3115.177M / 109.467M--
Aug 8, 20242024/Q2130.234M / 121.300M--
May 9, 20242024/Q1109.976M / 101.065M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 114.700M--
--2024/Q4-- / 109.600M--
Nov 12, 20242024/Q3115.177M / 109.467M--
Aug 8, 20242024/Q2130.234M / 121.300M--
May 9, 20242024/Q1109.976M / 101.065M--

Unlock Free Earnings Estimates

Organogenesis Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 22, 2024

Strong Buy

  • Buy

    75.00%
  • Hold

    25.00%
  • Sell

    0.00%

Price Target

No Data